close Video
NEW You can now listen to Fox News articles!
A new study has discovered that drugs for diabetes and weight loss could significantly reduce mortality for Americans.
Researchers at Swiss Re, a reinsurance company in Zurich, Switzerland, released estimations that GLP-1 drugs could lead to a 6.4% reduction in all-cause mortality in the U.S. by 2045.
In the U.K., more than a 5% reduction in mortality was projected over the same 20 years.
COULD GLP-1 WEIGHT-LOSS MEDICATIONS LIKE OZEMPIC BECOME THE 'EVERYTHING DRUG'?
The U.S. and U.K. share high obesity rates and a "strong uptake" in GLP-1 drugs, the researchers noted in a press release.
America has the world’s highest obesity rate, as more than 40% of the adult population is obese . About 30% of U.K. adults are obese.